ACIST MEDICAL SYSTEMS, INC.

ACIST Medical Systems, a subsidiary of the Bracco Group, manufactures diagnostic and interventional cardiology equipment for catheterization laboratories. The company specializes in contrast delivery systems, intravascular imaging (IVUS), and physiological assessment platforms used in coronary and peripheral interventions. ACIST's core product lines address three clinical domains: angiography (contrast management), imaging (high-definition intravascular ultrasound), and physiology (fractional flow reserve and pressure-derived assessments). The ACIST CVi contrast delivery system has been used in over 30 million clinical cases globally. The ACIST HDi represents the first high-definition IVUS system indicated for both coronary and peripheral vasculature. The ACIST RXi system, paired with Navvus II MicroCatheters, enables physiological assessment of complex coronary artery disease using standard 0.014-inch guidewires. Recently launched is the ACIST dPR algorithm, a non-hyperemic alternative for functional assessment. ACIST also markets the ACIST Pro diagnostic system in Europe. The company serves interventional cardiologists, cardiac surgeons, and interventional radiologists in hospitals and ambulatory cath labs. ACIST maintains manufacturing and service operations in Eden Prairie, Minnesota (global headquarters), with additional offices in Pleasanton, California; Heerlen, Netherlands; and Tokyo, Japan. The company provides clinical education, regulatory compliance support, consumables distribution, and 24/7 technical support. Products are cleared for use in the United States and hold CE marking in Europe.